marketcaparena

IRTC

iRhythm Holdings, Inc.

Company overview

Market capitalization
$3.71B
Employees
2,400
Latest publication
2026-09-29
About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USD
Total Revenue224,172,000USD208,890,000USD
Cost Of Revenue60,967,000USD60,835,000USD
Gross Profit163,205,000USD148,055,000USD
Selling General Administrative131,655,000USD122,004,000USD
Total Operating Expenses165,747,000USD139,288,000USD
Operating Income-2,542,000USD8,767,000USD
Total Other Income Expense Net2,161,000USD-2,741,000USD
Interest Income4,776,000USD5,337,000USD
Interest Expense3,294,000USD3,322,000USD
Litigation Settlement Expense13,950,000USD—
Income Before Tax-381,000USD6,026,000USD
Income Tax Expense0USD447,000USD
Net Income-381,000USD5,579,000USD
Research Development—21,046,000USD
Unclassified Operating Expenses—-3,762,000USD
Net Interest Income—2,015,000USD
Tax Provision—447,000USD
Net Income From Continuing Ops—5,579,000USD
Ebit—9,348,000USD
Ebitda—16,075,000USD
Depreciation And Amortization—6,727,000USD
Reconciled Depreciation—6,727,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets1,093,426,000USD1,006,365,000USD1,020,042,000USD995,214,000USD964,030,000USD926,098,000USD931,449,000USD909,688,000USD
Cash And Equivalents246,679,000USD———————
Cash And Short Term Investments591,274,000USD549,620,000USD583,763,000USD565,213,000USD545,540,000USD520,589,000USD535,553,000USD522,031,000USD
Short Term Investments344,595,000USD309,474,000USD347,751,000USD309,608,000USD236,435,000USD145,311,000USD115,956,000USD2,496,000USD
Long Term Investments73,682,000USD72,860,000USD69,913,000USD68,091,000USD64,897,000USD62,745,000USD61,902,000USD59,059,000USD
Total Current Assets755,954,000USD680,558,000USD702,765,000USD680,035,000USD663,917,000USD636,013,000USD645,819,000USD627,909,000USD
Other Current Assets57,893,000USD26,275,000USD21,662,000USD19,106,000USD17,825,000USD20,449,000USD16,286,000USD13,419,000USD
Other Non Current Assets50,468,000USD———————
Total Liabilities907,443,000USD———————
Total Current Liabilities196,098,000USD131,750,000USD151,890,000USD146,910,000USD132,211,000USD111,344,000USD110,920,000USD100,104,000USD
Other Current Liabilities157,570,000USD———————
Other Non Current Liabilities908,000USD———————
Total Stockholder Equity185,983,000USD161,210,000USD152,746,000USD121,893,000USD103,660,000USD86,665,000USD90,908,000USD71,766,000USD
Total Equity Including Noncontrolling Interest185,983,000USD———————
Deferred Revenue4,205,000USD———————
Net Receivables84,274,000USD80,863,000USD75,706,000USD76,157,000USD82,153,000USD80,639,000USD79,941,000USD77,427,000USD
Inventory22,513,000USD23,800,000USD21,634,000USD19,559,000USD18,399,000USD14,336,000USD14,039,000USD15,032,000USD
Property Plant Equipment Net204,102,000USD197,028,000USD193,426,000USD192,616,000USD184,452,000USD177,021,000USD172,656,000USD167,960,000USD
Goodwill862,000USD———————
Accounts Payable17,411,000USD8,559,000USD2,256,000USD8,278,000USD12,775,000USD11,946,000USD7,221,000USD7,593,000USD
Short Term Debt16,912,000USD16,793,000USD16,686,000USD16,526,000USD16,360,000USD16,140,000USD15,867,000USD15,522,000USD
Common Stock33,000USD33,000USD32,000USD32,000USD32,000USD32,000USD31,000USD31,000USD
Retained Earnings-817,760,000USD-817,379,000USD-803,446,000USD-809,025,000USD-803,813,000USD-789,595,000USD-758,895,000USD-757,562,000USD
Accumulated Other Comprehensive Income-188,000USD42,000USD403,000USD285,000USD-26,000USD143,000USD165,000USD-66,000USD
Total Liab—845,155,000USD867,296,000USD873,321,000USD860,370,000USD839,433,000USD840,541,000USD837,922,000USD
Other Current Liab—102,342,000USD128,747,000USD117,882,000USD97,325,000USD79,976,000USD80,892,000USD70,296,000USD
Capital Stock—33,000USD32,000USD32,000USD32,000USD32,000USD31,000USD31,000USD
Good Will—862,000USD862,000USD862,000USD862,000USD862,000USD862,000USD862,000USD
Cash—240,146,000USD236,012,000USD255,605,000USD309,105,000USD375,278,000USD419,597,000USD519,535,000USD
Current Deferred Revenue—4,056,000USD4,201,000USD4,224,000USD3,499,000USD3,282,000USD2,932,000USD3,031,000USD
Net Debt—489,145,000USD495,172,000USD477,406,000USD425,639,000USD360,224,000USD317,312,000USD215,827,000USD
Short Long Term Debt Total—729,291,000USD731,184,000USD733,011,000USD734,744,000USD735,502,000USD736,909,000USD735,362,000USD
Long Term Debt—650,313,000USD649,504,000USD648,753,000USD648,007,000USD647,237,000USD646,443,000USD645,821,000USD
Property Plant Equipment Gross—293,262,000USD284,618,000USD278,803,000USD265,466,000USD252,930,000USD243,875,000USD233,890,000USD
Common Stock Shares Outstanding—32,507,000shares33,332,000shares32,170,000shares31,990,000shares31,590,000shares31,343,000shares31,262,000shares
Non Current Assets Total—325,807,000USD317,277,000USD315,179,000USD300,113,000USD290,085,000USD285,630,000USD281,779,000USD
Non Current Liabilities Total—713,405,000USD715,406,000USD726,411,000USD728,159,000USD728,089,000USD729,621,000USD737,818,000USD
Non Current Liabilities Other—907,000USD908,000USD9,926,000USD9,775,000USD8,727,000USD8,579,000USD17,978,000USD
Non Currrent Assets Other—55,057,000USD53,076,000USD53,610,000USD49,902,000USD49,457,000USD50,210,000USD53,898,000USD
Net Working Capital—548,808,000USD550,875,000USD533,125,000USD531,706,000USD524,669,000USD534,899,000USD527,805,000USD
Unclassified Non Current Liabilities—62,185,000USD64,994,000USD67,732,000USD70,377,000USD72,125,000USD74,599,000USD74,019,000USD
Unclassified Equity—978,481,000USD955,725,000USD930,569,000USD907,435,000USD876,053,000USD849,576,000USD829,332,000USD
Unclassified Current Liabilities————2,252,000USD—4,008,000USD3,662,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets1,020,042,000USD931,449,000USD433,144,000USD448,222,000USD462,967,000USD511,739,000USD306,212,000USD119,710,000USD
Other Current Assets21,662,000USD16,286,000USD21,591,000USD10,555,000USD9,693,000USD7,363,000USD4,337,000USD8,200,000USD
Total Liab867,296,000USD840,541,000USD223,047,000USD208,410,000USD183,452,000USD170,127,000USD170,803,000USD65,288,000USD
Total Stockholder Equity152,746,000USD90,908,000USD210,097,000USD239,812,000USD279,515,000USD341,612,000USD135,409,000USD54,422,000USD
Other Current Liab128,747,000USD80,892,000USD80,485,000USD63,109,000USD51,486,000USD40,532,000USD32,714,000USD26,827,000USD
Common Stock32,000USD31,000USD31,000USD28,000USD27,000USD27,000USD25,000USD23,000USD
Capital Stock32,000USD31,000USD31,000USD28,000USD27,000USD27,000USD25,000USD23,000USD
Retained Earnings-803,446,000USD-758,895,000USD-645,606,000USD-522,200,000USD-406,045,000USD-304,684,000USD-260,393,000USD-203,515,000USD
Good Will862,000USD862,000USD862,000USD862,000USD862,000USD862,000USD862,000USD862,000USD
Cash236,012,000USD419,597,000USD36,173,000USD78,832,000USD127,562,000USD88,628,000USD20,462,000USD20,023,000USD
Cash And Short Term Investments583,763,000USD535,553,000USD133,764,000USD213,144,000USD239,131,000USD335,217,000USD140,551,000USD78,343,000USD
Total Current Assets702,765,000USD645,819,000USD230,812,000USD288,772,000USD305,522,000USD377,825,000USD172,792,000USD106,482,000USD
Total Current Liabilities151,890,000USD110,920,000USD107,370,000USD89,096,000USD87,853,000USD65,665,000USD52,066,000USD30,236,000USD
Current Deferred Revenue4,201,000USD2,932,000USD3,306,000USD3,051,000USD3,049,000USD930,000USD1,251,000USD1,243,000USD
Net Debt495,172,000USD317,312,000USD93,651,000USD52,206,000USD-9,851,000USD33,842,000USD108,133,000USD14,876,000USD
Short Term Debt16,686,000USD15,867,000USD15,159,000USD13,031,000USD22,809,000USD19,838,000USD9,858,000USD—
Short Long Term Debt Total731,184,000USD736,909,000USD129,824,000USD131,038,000USD117,711,000USD122,470,000USD128,595,000USD34,899,000USD
Long Term Debt649,504,000USD646,443,000USD34,950,000USD34,935,000USD9,690,000USD21,339,000USD32,989,000USD34,899,000USD
Long Term Investments69,913,000USD61,902,000USD3,000,000USD——0USD8,030,000USD0USD
Short Term Investments347,751,000USD115,956,000USD97,591,000USD134,312,000USD111,569,000USD246,589,000USD120,089,000USD58,320,000USD
Net Receivables75,706,000USD79,941,000USD61,484,000USD49,918,000USD46,430,000USD29,932,000USD23,867,000USD19,790,000USD
Inventory21,634,000USD14,039,000USD13,973,000USD15,155,000USD10,268,000USD5,313,000USD4,037,000USD2,062,000USD
Accounts Payable2,256,000USD7,221,000USD5,543,000USD7,517,000USD10,509,000USD4,365,000USD8,243,000USD2,284,000USD
Property Plant Equipment Net193,426,000USD172,656,000USD153,431,000USD136,336,000USD140,531,000USD118,961,000USD116,588,000USD9,158,000USD
Property Plant Equipment Gross284,618,000USD243,875,000USD203,934,000USD136,336,000USD140,531,000USD118,961,000USD116,588,000USD9,158,000USD
Accumulated Other Comprehensive Income403,000USD165,000USD-112,000USD-396,000USD-61,000USD11,000USD82,000USD-41,000USD
Common Stock Shares Outstanding32,003,999shares31,196,000shares30,528,000shares29,915,720shares29,331,010shares27,754,404shares25,265,918shares23,885,858shares
Non Current Assets Total317,277,000USD285,630,000USD202,332,000USD159,450,000USD157,445,000USD133,914,000USD133,420,000USD13,228,000USD
Non Current Liabilities Total715,406,000USD729,621,000USD115,677,000USD119,314,000USD95,599,000USD104,462,000USD118,737,000USD35,052,000USD
Non Current Liabilities Other908,000USD8,579,000USD1,012,000USD1,307,000USD697,000USD83,123,000USD85,748,000USD—
Non Currrent Assets Other53,076,000USD50,210,000USD45,039,000USD22,252,000USD16,052,000USD14,091,000USD7,940,000USD3,208,000USD
Net Working Capital550,875,000USD534,899,000USD123,442,000USD199,676,000USD217,669,000USD312,160,000USD120,726,000USD76,246,000USD
Unclassified Non Current Liabilities64,994,000USD74,599,000USD79,715,000USD81,765,000USD84,515,000USD-1,830,000USD——
Unclassified Equity955,725,000USD849,576,000USD855,753,000USD762,352,000USD685,567,000USD646,231,000USD395,670,000USD257,932,000USD
Unclassified Current Liabilities—4,008,000USD2,877,000USD2,388,000USD-11,667,000USD-11,667,000USD-1,944,000USD—
Other Liab———1,307,000USD697,000USD1,830,000USD—153,000USD
Other Assets———22,252,000USD16,052,000USD98,805,000USD7,940,000USD3,208,000USD
Net Tangible Assets———238,950,000USD278,653,000USD340,750,000USD134,547,000USD51,275,000USD
Unclassified Non Current Assets———-22,252,000USD-16,052,000USD-98,805,000USD-7,940,000USD-3,208,000USD
Short Long Term Debt————11,667,000USD11,667,000USD1,944,000USD—
Deferred Long Term Liab———————153,000USD
Unclassified Current Assets———————-1,913,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-13,933,000USD5,579,000USD-5,212,000USD-14,218,000USD-30,700,000USD-1,333,000USD-46,182,000USD-20,107,000USD
Depreciation4,312,000USD6,727,000USD6,621,000USD4,451,000USD4,591,000USD6,604,000USD1,415,000USD6,400,000USD
Stock Based Compensation21,491,000USD21,106,000USD21,006,000USD22,827,000USD23,344,000USD16,008,000USD17,158,000USD21,821,000USD
Other Non Cash Items29,345,000USD20,195,000USD25,509,000USD29,564,000USD31,410,000USD20,909,000USD-21,698,000USD19,998,000USD
Change To Account Receivables-33,000,000USD-19,054,000USD-19,461,000USD-26,791,000USD-30,125,000USD-23,240,000USD-9,164,000USD-14,998,000USD
Change To Inventory-2,424,000USD-2,062,000USD-1,849,000USD-4,213,000USD-388,000USD817,000USD425,000USD-543,000USD
Change In Working Capital-67,388,000USD-27,395,000USD-13,041,000USD-14,965,000USD-36,536,000USD-22,956,000USD73,654,000USD-16,272,000USD
Total Cash From Operating Activities-26,173,000USD26,212,000USD34,883,000USD27,659,000USD-7,891,000USD19,232,000USD24,347,000USD11,840,000USD
Capital Expenditures-6,905,000USD-11,723,000USD-14,831,000USD-10,369,000USD-9,419,000USD-6,844,000USD-8,834,000USD-8,488,000USD
Free Cash Flow-33,078,000USD14,489,000USD20,052,000USD17,290,000USD-17,310,000USD12,388,000USD15,513,000USD3,352,000USD
Investments37,120,000USD-37,075,000USD-89,204,000USD-100,915,000USD-38,139,000USD-122,159,000USD-55,334,000USD14,512,000USD
Total Cashflows From Investing Activities30,215,000USD-48,798,000USD-89,204,000USD-100,915,000USD-38,139,000USD-122,159,000USD-55,334,000USD14,512,000USD
Total Cash From Financing Activities149,000USD2,959,000USD825,000USD7,094,000USD1,729,000USD2,987,000USD-35,000USD3,788,000USD
Change In Cash4,134,000USD-19,593,000USD-53,500,000USD-66,173,000USD-44,319,000USD-99,937,999USD-31,017,000USD30,131,000USD
Begin Period Cash Flow244,370,000USD263,963,000USD317,463,000USD383,636,000USD427,955,000USD519,534,999USD558,910,000USD520,421,000USD
End Period Cash Flow248,504,000USD244,370,000USD263,963,000USD317,463,000USD383,636,000USD419,597,000USD527,893,000USD550,552,000USD
Other Cashflows From Financing Activities149,000USD—825,000USD—1,729,000USD597,643,000USD148,000USD3,788,000USD
Net Borrowings—0USD0USD0USD0USD0USD0USD—
Sale Purchase Of Stock—0USD0USD0USD0USD0USD25,000,000USD0USD
Unclassified Financing Cash Flow—2,959,000USD—7,094,000USD—-594,656,000USD-25,183,000USD—
Unclassified Investing Cash Flow——14,831,000USD10,369,000USD9,419,000USD6,844,000USD23,834,000USD-14,512,000USD
Other Cashflows From Investing Activities——————-15,000,000USD23,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-44,551,000USD-113,289,000USD-123,406,000USD-116,155,000USD-101,361,000USD-43,830,000USD-54,568,000USD-48,280,000USD
Depreciation26,479,000USD25,777,000USD22,144,000USD19,609,000USD16,594,000USD6,900,000USD3,445,000USD2,269,000USD
Stock Based Compensation88,283,000USD75,978,000USD77,204,000USD57,740,000USD54,527,000USD41,515,000USD26,241,000USD16,329,000USD
Other Non Cash Items102,349,000USD102,506,000USD76,003,000USD81,303,000USD38,715,000USD6,030,000USD8,990,000USD-2,931,000USD
Change To Account Receivables-95,431,000USD-91,920,000USD-81,193,000USD-61,837,000USD-53,572,000USD-37,957,000USD-28,725,000USD-22,885,000USD
Change To Inventory-8,512,000USD-224,000USD979,000USD-5,108,000USD-4,960,000USD-1,389,000USD-1,974,000USD-380,000USD
Change In Working Capital-91,697,000USD-99,116,000USD-102,046,000USD-65,509,000USD-46,228,000USD-56,235,000USD-29,734,000USD-13,870,000USD
Total Cash From Operating Activities80,863,000USD3,390,000USD-50,101,000USD-23,012,000USD-37,753,000USD-13,759,000USD-21,863,000USD-29,068,000USD
Capital Expenditures-46,342,000USD-33,942,000USD-40,424,000USD-29,830,000USD-28,066,999USD-13,551,000USD-20,457,000USD-5,180,000USD
Free Cash Flow34,521,000USD-30,552,000USD-90,525,000USD-52,842,000USD-65,819,999USD-27,310,000USD-42,320,000USD-34,248,000USD
Investments-230,714,000USD-122,983,000USD-10,723,000USD-22,604,000USD133,331,000USD-118,840,000USD-68,817,000USD39,297,000USD
Total Cashflows From Investing Activities-277,056,000USD-122,983,000USD-1,209,000USD-52,434,000USD105,264,000USD-132,391,000USD-89,274,000USD34,117,000USD
Net Borrowings0USD619,839,000USD0USD13,534,000USD-11,667,000USD-1,944,000USD-1,944,000USD861,000USD
Total Cash From Financing Activities12,607,000USD511,381,000USD8,820,000USD26,716,000USD-28,577,000USD214,316,000USD111,576,000USD6,303,000USD
Sale Purchase Of Stock0USD-25,000,000USD0USD13,182,000USD-25,853,000USD-10,009,000USD-5,288,000USD-3,877,000USD
Change In Cash-183,585,000USD391,782,000USD-42,659,000USD-48,730,000USD38,934,000USD68,166,000USD439,000USD11,352,000USD
Begin Period Cash Flow419,597,000USD36,173,000USD78,832,000USD127,562,000USD88,628,000USD20,462,000USD20,023,000USD8,671,000USD
End Period Cash Flow236,012,000USD427,955,000USD36,173,000USD78,832,000USD127,562,000USD88,628,000USD20,462,000USD20,023,000USD
Other Cashflows From Investing Activities-277,056,000USD-89,041,000USD—-52,434,000USD133,331,000USD-118,840,000USD-68,817,000USD39,322,000USD
Other Cashflows From Financing Activities12,607,000USD-83,458,000USD8,820,000USD13,182,000USD-25,853,000USD10,235,000USD4,207,000USD2,803,000USD
Unclassified Investing Cash Flow277,056,000USD122,983,000USD49,938,000USD52,434,000USD-133,331,001USD118,840,000USD68,817,000USD-39,322,000USD
Unclassified Operating Cash Flow—11,534,000USD———31,861,000USD23,763,000USD17,415,000USD
Change To Liabilities———11,480,000USD8,254,000USD-2,573,000USD11,606,000USD10,584,000USD
Issuance Of Capital Stock———0USD-362,000USD206,025,000USD116,864,000USD0USD
Cash And Cash Equivalents Changes———-48,730,000USD—68,166,000USD439,000USD11,352,000USD
Unclassified Financing Cash Flow———-13,182,000USD60,649,000USD226,043,000USD114,601,000USD6,516,000USD
Dividends Paid————-25,853,000USD-10,009,000USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductCenters For Medicare Medicaid Services58,550,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductCommercial Payors113,783,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductHealthcare Institutions37,782,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductNon Contracted Third Party Payors14,057,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductCenters For Medicare Medicaid Services51,389,000USD0001388658-26-000039
Q1 2026Quarterly · 2026-03-31ProductCommercial Payors106,804,000USD0001388658-26-000039
Q1 2026Quarterly · 2026-03-31ProductHealthcare Institutions30,154,000USD0001388658-26-000039
Q1 2026Quarterly · 2026-03-31ProductNon Contracted Third Party Payors11,043,000USD0001388658-26-000039
Q4 2025Quarterly · 2025-12-31ProductCenters For Medicare And Medicaid49,193,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductCommercial Payors111,699,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductHealthcare Institutions34,319,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductNon Contracted Third Party Payors13,679,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductCenters For Medicare And Medicaid179,350,000USD0001388658-26-000011
FY 2025Yearly · 2025-12-31ProductCommercial Payors392,234,000USD0001388658-26-000011
FY 2025Yearly · 2025-12-31ProductHealthcare Institutions125,613,000USD0001388658-26-000011
FY 2025Yearly · 2025-12-31ProductNon Contracted Third Party Payors49,941,000USD0001388658-26-000011
Q3 2025Quarterly · 2025-09-30ProductCenters For Medicare And Medicaid47,564,000USD0001388658-25-000217
Q3 2025Quarterly · 2025-09-30ProductCommercial Payors99,014,000USD0001388658-25-000217
Q3 2025Quarterly · 2025-09-30ProductHealthcare Institutions32,791,000USD0001388658-25-000217
Q3 2025Quarterly · 2025-09-30ProductNon Contracted Third Party Payors13,515,000USD0001388658-25-000217
Q2 2025Quarterly · 2025-06-30ProductCenters For Medicare And Medicaid44,481,000USD0001388658-25-000196
Q2 2025Quarterly · 2025-06-30ProductCommercial Payors97,719,000USD0001388658-25-000196
Q2 2025Quarterly · 2025-06-30ProductHealthcare Institutions31,830,000USD0001388658-25-000196
Q2 2025Quarterly · 2025-06-30ProductNon Contracted Third Party Payors12,657,000USD0001388658-25-000196
Q1 2025Quarterly · 2025-03-31ProductCenters For Medicare Medicaid Services38,112,000USD0001388658-26-000039
Q1 2025Quarterly · 2025-03-31ProductCommercial Payors83,802,000USD0001388658-26-000039
Q1 2025Quarterly · 2025-03-31ProductHealthcare Institutions26,673,000USD0001388658-26-000039
Q1 2025Quarterly · 2025-03-31ProductNon Contracted Third Party Payors10,090,000USD0001388658-26-000039
Q4 2024Quarterly · 2024-12-31ProductCenters For Medicare And Medicaid38,338,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductCommercial Payors83,320,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductHealthcare Institutions29,846,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductNon Contracted Third Party Payors12,821,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductCenters For Medicare And Medicaid142,389,000USD0001388658-26-000011
FY 2024Yearly · 2024-12-31ProductCommercial Payors311,605,000USD0001388658-26-000011
FY 2024Yearly · 2024-12-31ProductHealthcare Institutions95,115,000USD0001388658-26-000011
FY 2024Yearly · 2024-12-31ProductNon Contracted Third Party Payors42,730,000USD0001388658-26-000011
Q3 2024Quarterly · 2024-09-30ProductCenters For Medicare And Medicaid36,011,000USD0001388658-25-000217
Q3 2024Quarterly · 2024-09-30ProductCommercial Payors77,257,000USD0001388658-25-000217
Q3 2024Quarterly · 2024-09-30ProductHealthcare Institutions23,461,000USD0001388658-25-000217
Q3 2024Quarterly · 2024-09-30ProductNon Contracted Third Party Payors10,809,000USD0001388658-25-000217
FY 2023Yearly · 2023-12-31ProductCenters For Medicare And Medicaid122,414,000USD0001388658-26-000011
FY 2023Yearly · 2023-12-31ProductCommercial Payors267,195,000USD0001388658-26-000011
FY 2023Yearly · 2023-12-31ProductHealthcare Institutions71,001,000USD0001388658-26-000011
FY 2023Yearly · 2023-12-31ProductNon Contracted Third Party Payors32,071,000USD0001388658-26-000011
FY 2022Yearly · 2022-12-31ProductCenters For Medicare And Medicaid103,032,000USD0001388658-25-000028
FY 2022Yearly · 2022-12-31ProductCommercial Payors223,984,000USD0001388658-25-000028
FY 2022Yearly · 2022-12-31ProductHealthcare Institutions59,772,000USD0001388658-25-000028
FY 2022Yearly · 2022-12-31ProductNon Contracted Third Party Payors24,133,000USD0001388658-25-000028
FY 2021Yearly · 2021-12-31ProductCenters For Medicare And Medicaid44,529,000USD0001388658-24-000014
FY 2021Yearly · 2021-12-31ProductCommercial Payors193,871,000USD0001388658-24-000014
FY 2021Yearly · 2021-12-31ProductHealthcare Institutions57,496,000USD0001388658-24-000014
FY 2021Yearly · 2021-12-31ProductNon Contracted Third Party Payors26,929,000USD0001388658-24-000014
FY 2020Yearly · 2020-12-31ProductCenters For Medicare And Medicaid72,536,000USD0001388658-23-000007
FY 2020Yearly · 2020-12-31ProductCommercial Payors135,939,000USD0001388658-23-000007
FY 2020Yearly · 2020-12-31ProductHealthcare Institutions41,396,000USD0001388658-23-000007
FY 2020Yearly · 2020-12-31ProductNon Contracted Third Party Payors15,295,000USD0001388658-23-000007
FY 2019Yearly · 2019-12-31ProductCenters For Medicare And Medicaid58,918,000USD0001388658-22-000020
FY 2019Yearly · 2019-12-31ProductCommercial Payors101,845,000USD0001388658-22-000020
FY 2019Yearly · 2019-12-31ProductHealthcare Institutions43,019,000USD0001388658-22-000020
FY 2019Yearly · 2019-12-31ProductNon Contracted Third Party Payors10,770,000USD0001388658-22-000020
FY 2018Yearly · 2018-12-31ProductCenters For Medicare And Medicaid40,482,000USD0001388658-21-000039
FY 2018Yearly · 2018-12-31ProductCommercial Payors56,949,000USD0001388658-21-000039
FY 2018Yearly · 2018-12-31ProductHealthcare Institutions37,399,000USD0001388658-21-000039
FY 2018Yearly · 2018-12-31ProductNon Contracted Third Party Payors12,447,000USD0001388658-21-000039

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.